KBRA Assigns and Affirms Ratings for Mandatory Redeemable Preferred Shares Issued by Calamos Strategic Total Return Fund

KBRA assigned an ‘AA-’ rating to Calamos Strategic Total Return Fund’s $151.0M Series H Mandatory Redeemable Preferred Shares (MRPS) and concurrently affirmed the ratings on the Fund’s outstanding Series C, F, and G MRPS. The Outlook on all ratings is Stable, with the action citing a stable portfolio composition primarily invested in U.S.-domiciled common stocks (and convertible securities). Overall, this is a credit-strengthening confirmation that is unlikely to be market-moving beyond the security/issuer.

Analysis

This is primarily a liability-side confirmation, not a change in the earnings engine. For CSQ, the meaningful effect is that the fund can continue financing a leveraged capital structure without signaling stress, which lowers the odds of a forced asset sale in a drawdown and modestly supports the common’s discount-to-NAV stability. The preferred holders get the cleaner benefit: a rated, redeemable security in a world where many closed-end-fund preferreds trade on liquidity and structure more than on headline credit quality.

The second-order read-through is for the broader leveraged-income complex. If markets remain calm, this should tighten the funding spread on similar CEF preferreds and support issuance at the margin; if equity vol rises, however, the rating will matter less than portfolio mark-to-market and coverage ratios. The real risk window is 1-3 months if rates/vol reprice wider, because that would pressure CEF discounts and make leverage optics matter again; over 6-18 months, distribution coverage and asset coverage tests are what will determine whether this remains benign or becomes a funding overhang.

Contrarian view: the market may overread the rating as a broad endorsement of the fund’s asset quality. It is not—this mostly validates the structure, not the underlying portfolio’s drawdown tolerance. If the new preferred prints tight to other investment-grade preferreds, upside is limited; the better trade is to wait for any widening driven by risk-off flows rather than chase the paper on the announcement.

Key Decisions for Investors

• No immediate directional trade in CSQ common; treat this as a financing confirmation rather than a catalyst. Reassess only if leverage usage or coverage metrics deteriorate on the next report.
• If CSQ Series H preferred trades wider than comparable investment-grade preferreds, buy on weakness for carry; cut if broader preferred spreads widen materially or if equity vol spikes.
• Watch CSQ discount-to-NAV and asset coverage over the next 1-3 months; a widening discount plus weaker coverage would falsify the stable-funding thesis and argue against adding exposure.
• Prefer higher-quality preferred exposure via PFF/PGX over lower-quality leveraged-income credits if rates or volatility back up; this announcement alone is not enough to justify chasing yield in the CEF complex.